2-naphthol has been researched along with moclobemide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banken, L; Dingemanse, J; Guentert, TW; Holford, NH | 1 |
| Bitsios, P; Bradshaw, CM; Langley, RW; Pyykkö, K; Scheinin, M; Szabadi, E; Tavernor, S | 1 |
2 trial(s) available for 2-naphthol and moclobemide
| Article | Year |
|---|---|
Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.
Topics: Administration, Oral; Adult; Benzamides; Biological Availability; Chromatography, High Pressure Liquid; Humans; Hydroxyindoleacetic Acid; Male; Metabolic Clearance Rate; Moclobemide; Models, Biological; Monoamine Oxidase Inhibitors; Naphthols; Propylene Glycols; Random Allocation | 1994 |
Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
Topics: Adult; Analysis of Variance; Benzamides; Blood Platelets; Double-Blind Method; Drug Interactions; Feasibility Studies; Humans; Male; Meiosis; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Naphthols; Propylene Glycols; Pupil; Selegiline; Tyramine | 1998 |